Form 4: Moderna President's RSU Vesting & Tax Sales

Moderna's President, Stephen Hoge, reported the vesting of restricted stock units and subsequent sales to cover tax obligations.

Summary

• Moderna President Stephen Hoge converted 1,437 restricted stock units (RSUs) into common stock on November 26, 2025, as part of a pre-planned transaction.
• On the same date, 695 shares were disposed of at $24.75 to satisfy tax withholding obligations related to the RSU vesting.
• Hoge also converted 610 RSUs into common stock on November 28, 2025, under a pre-planned transaction.
• Concurrently, 295 shares were disposed of at $25.01 to cover tax withholding obligations for this RSU vesting.
• Following these transactions, Hoge directly beneficially owns 1,454,569 shares of Moderna common stock.
• He also indirectly owns 4,116 shares via Valhalla, LLC and 151,933 shares via a trust for his spouse and children, disclaiming Section 16 beneficial ownership for the trust shares except for pecuniary interest.
• Remaining direct derivative holdings include 12,931 Restricted Stock Units from one award and 3,053 Restricted Stock Units from another award.

Sentiment

Score: 6

Explanation: The filing reports routine RSU vesting and tax-related share sales by a key executive. While there's a slight reduction in direct ownership due to tax withholding, the overall continued equity holding and ongoing vesting schedule are neutral to slightly positive, indicating continued alignment with shareholder interests and the execution of a pre-planned compensation strategy.

Positives

• Stephen Hoge continues to hold a significant direct beneficial ownership of 1,454,569 shares of Moderna common stock, indicating continued alignment with shareholder interests.
• The vesting of Restricted Stock Units represents the fulfillment of compensation agreements and continued long-term incentive alignment for a key executive.
• Remaining RSU awards (12,931 and 3,053 units) provide future equity upside potential for the executive.

Negatives

• A total of 990 shares (695 + 295) were disposed of to cover tax withholding obligations, resulting in a reduction of direct share ownership.

Future Outlook

The filing indicates ongoing vesting schedules for Restricted Stock Units, with remaining units vesting in quarterly installments following initial vesting dates of February 27, 2025, and February 28, 2024.

Industry Context

NA

Related Party Transactions

• Indirect ownership of 151,933 shares of common stock by a trust for the benefit of Dr. Hoge's spouse and children, with his spouse as a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

Stakeholder Impact

• Shareholders: The filing indicates continued equity alignment of a key executive, which can be viewed positively. The disposition of shares for tax purposes is a standard practice and not indicative of a lack of confidence.
• Employees: The vesting of RSUs is part of standard executive compensation, which can serve as a model for broader employee equity programs.

Next Steps

• Continued vesting of remaining Restricted Stock Units in twelve equal quarterly installments following the initial vesting dates of February 27, 2025, and February 28, 2024.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions involving the vesting of restricted stock units and subsequent sales to cover tax obligations, executed under a Rule 10b5-1 plan. Such transactions are standard for executives receiving equity compensation and do not typically signal a change in the company's fundamental outlook or the executive's confidence. While there's a minor reduction in direct ownership due to tax withholding, the executive retains a substantial direct and indirect stake. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as it provides no new material information to alter an existing investment thesis.

Keywords

Moderna, MRNA, Stephen Hoge, insider transaction, Form 4, RSU vesting, stock sale, tax withholding, beneficial ownership, 10b5-1 plan